Laurence Lodé

2.3k total citations
30 papers, 1.3k citations indexed

About

Laurence Lodé is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Laurence Lodé has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 11 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Laurence Lodé's work include Multiple Myeloma Research and Treatments (13 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Laurence Lodé is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Laurence Lodé collaborates with scholars based in France, United States and Sweden. Laurence Lodé's co-authors include Hervé Avet‐Loiseau, Stéphane Minvielle, Régis Bataille, Jean‐Luc Harousseau, Florence Magrangeas, Philippe Moreau, L. Campion, Richard Garand, Pascal Jézéquel and Catherine Guérin‐Charbonnel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Laurence Lodé

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laurence Lodé France	16	878	848	429	209	132	30	1.3k
Luděk Pour Czechia	17	682 0.8×	805 0.9×	396 0.9×	176 0.8×	110 0.8×	109	1.1k
M. Rapp France	14	695 0.8×	637 0.8×	415 1.0×	195 0.9×	140 1.1×	29	1.2k
Luc Van Rompaey Belgium	16	568 0.6×	493 0.6×	594 1.4×	411 2.0×	140 1.1×	31	1.4k
Relja Popovic United States	23	2.3k 2.6×	1.5k 1.8×	403 0.9×	332 1.6×	140 1.1×	41	3.0k
Heiko Becker Germany	19	1.1k 1.2×	1.1k 1.3×	271 0.6×	423 2.0×	53 0.4×	59	1.9k
Ton van Agthoven Netherlands	11	528 0.6×	586 0.7×	216 0.5×	416 2.0×	71 0.5×	13	1.2k
Dominik Dytfeld Poland	14	920 1.0×	1.0k 1.2×	652 1.5×	113 0.5×	64 0.5×	75	1.3k
Masato Shikami Japan	18	703 0.8×	451 0.5×	381 0.9×	126 0.6×	73 0.6×	31	1.1k
Jingrui Jiang United States	13	432 0.5×	252 0.3×	251 0.6×	170 0.8×	40 0.3×	22	868
Chetasi Talati United States	16	512 0.6×	592 0.7×	247 0.6×	326 1.6×	81 0.6×	78	1.1k

Countries citing papers authored by Laurence Lodé

Since Specialization

Citations

This map shows the geographic impact of Laurence Lodé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Lodé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Lodé more than expected).

Fields of papers citing papers by Laurence Lodé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Lodé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Lodé. The network helps show where Laurence Lodé may publish in the future.

Co-authorship network of co-authors of Laurence Lodé

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Lodé. A scholar is included among the top collaborators of Laurence Lodé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Lodé. Laurence Lodé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Willem, Catherine, Christelle Volteau, Nolwenn Legrand, et al.. (2016). Impact of Graft-Versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation. Transplantation. 101(9). 2092–2101. 4 indexed citations

Bou‐Hanna, Chantal, Anne Jarry, Laurence Lodé, et al.. (2015). Acute cytotoxicity of MIRA-1/NSC19630, a mutant p53-reactivating small molecule, against human normal and cancer cells via a caspase-9-dependent apoptosis. Cancer Letters. 359(2). 211–217. 38 indexed citations

Péterlin, Pierre, Jacques Delaunay, Thierry Guillaume, et al.. (2014). Complete Donor T Cell Chimerism Predicts Lower Relapse Incidence after Standard Double Umbilical Cord Blood Reduced-Intensity Conditioning Regimen Allogeneic Transplantation in Adults. Biology of Blood and Marrow Transplantation. 21(1). 180–184. 10 indexed citations

Bourgeois, Amandine Le, Myriam Labopin, Thierry Guillaume, et al.. (2014). Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults. Experimental Hematology. 42(11). 945–954. 11 indexed citations

Adamia, Sophia, Benjamin Haibe‐Kains, Patrick M. Pilarski, et al.. (2013). A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets. Clinical Cancer Research. 20(5). 1135–1145. 79 indexed citations

Bourgeois, Amandine Le, Catherine Mohr, Thierry Guillaume, et al.. (2013). Comparison of Outcomes after Two Standards-of-Care Reduced-Intensity Conditioning Regimens and Two Different Graft Sources for Allogeneic Stem Cell Transplantation in Adults with Hematologic Diseases: A Single-Center Analysis. Biology of Blood and Marrow Transplantation. 19(6). 934–939. 16 indexed citations

Lodé, Laurence, Philippe Moreau, Catherine Godon, et al.. (2013). Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease. Blood Cancer Journal. 3(11). e163–e163. 3 indexed citations

David, Emmanuelle, Soraya Saïagh, Sylvain Bercegeay, et al.. (2013). New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Laboratory Investigation. 93(10). 1100–1114. 36 indexed citations

Magrangeas, Florence, Hervé Avet‐Loiseau, Wilfried Gouraud, et al.. (2012). Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia. 27(2). 473–481. 83 indexed citations

10.

Chevallier, Patrice, Myriam Labopin, Pascal Turlure, et al.. (2011). A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study. Leukemia. 25(6). 939–944. 91 indexed citations

11.

Lodé, Laurence, Marion Eveillard, Valérie Trichet, et al.. (2010). Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma. Haematologica. 95(11). 1973–1976. 105 indexed citations

12.

Decaux, Olivier, Laurence Lodé, Florence Magrangeas, et al.. (2008). Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome. Journal of Clinical Oncology. 26(29). 4798–4805. 269 indexed citations

13.

Decaux, O., Laurence Lodé, Stéphane Minvielle, & Hervé Avet‐Loiseau. (2007). Anomalies génétiques dans le myélome : rôle dans l'oncogenèse et implications pronostiques. La Revue de Médecine Interne. 28(10). 677–681. 3 indexed citations

14.

Ricolleau, Gabriel, Catherine Guérin‐Charbonnel, Laurence Lodé, et al.. (2006). Surface‐enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node‐negative breast cancer tumors. PROTEOMICS. 6(6). 1963–1975. 73 indexed citations

15.

Lodé, Laurence, Soraya Wuillème, & Hervé Avet‐Loiseau. (2005). Facteurs pronostiques biologiques dans le myélome multiple. Hématologie. 11(5). 346–350. 2 indexed citations

16.

Wuillème, Soraya, Nelly Robillard, Laurence Lodé, et al.. (2004). Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma. Leukemia. 19(2). 275–278. 89 indexed citations

17.

Magrangeas, Florence, Laurence Lodé, Soraya Wuillème, Stéphane Minvielle, & Hervé Avet‐Loiseau. (2004). Genetic heterogeneity in multiple myeloma. Leukemia. 19(2). 191–194. 25 indexed citations

18.

Avet‐Loiseau, Hervé, Soraya Wuillème, Nelly Robillard, et al.. (2004). Ploidy, as Detected by Fluorescence In Situ Hybridization, Defines Different Subgroups in Multiple Myeloma.. Blood. 104(11). 4857–4857. 9 indexed citations

19.

Avet‐Loiseau, Hervé, Richard Garand, Laurence Lodé, Nelly Robillard, & Régis Bataille. (2003). 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia. Seminars in Oncology. 30(2). 153–155. 43 indexed citations

20.

Scotet, Virginie, Marc De Braekeleer, M.‐P. Audrézet, et al.. (2001). Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis. Clinical Genetics. 59(1). 42–47. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact